Caudal Dexamethasone - Bupivacaine in Neonates

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-28
SponsorAin Shams University

About this trial

Randomied controlled study Evaluate the effects of caudal Dexamethasone in neonates

Eligibility criteria

Qualifiers

full term neonate

ASA I & ASA II

Scheduled for inguinal hernia repair

Disqualifiers

Patients with allergies to studied drugs

body weight <3 kilograms

parents refusal

Trial design

Treatments tested in this trial

  • We add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonsates undergoing inguinal hernia repair in Dexamethasone - Bupivacaine group

Treatment groups

150 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators